GlassScriptPhysician profile
Matthew Horn
NPI 1912015637
$90,486.13
in general payments reported to CMS, 2019-2025
11 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $7,322 · 2021: $18K · 2022: $24K · 2023: $13K · 2024: $6,647 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $1,473 · Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,990.00 |
| Travel and Lodging | $1,473.25 |
| Food and Beverage | $1,303.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $89,047.52 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.58 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $313.85 | 2019-2022 | |
| Penumbra, INC. | $140.06 | 2021 | |
| Allergan, INC. | $124.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.70 | 2022 | |
| Intuitive Surgical, INC. | $105.76 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.34 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $91.25 | 2019 | |
| Glaxosmithkline, LLC. | $20.28 | 2022 | |
| Sunovion Pharmaceuticals INC. | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Horn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.